BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MEN1, ENSG00000133895, 4221 AND Treatment
207 results:

  • 1. Gastric neuroendocrine neoplasms.
    Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
    Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
    Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
    J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Individualized approach for men1-associated duodenopancreatic neuroendocrine neoplasms].
    Manoharan J; Albers MB; Bartsch DK
    Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Management of Gastric Neuroendocrine Tumors: A Review.
    Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
    Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
    Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
    Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography.
    Said M; Krogh J; Feldt-Rasmussen U; Rasmussen ÅK; Kristensen TS; Rossing CM; Johannesen HH; Oturai P; Holmager P; Kjaer A; Klose M; Langer S; Knigge U; Andreassen M
    J Neuroendocrinol; 2023 Aug; 35(8):e13322. PubMed ID: 37564005
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinically Defined Mutations in
    Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
    Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
    Deng J; Liao X; Cao H
    Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. INSULINOMA OF THE TAIL OF THE PANCREAS - A CASE REPORT.
    Mucha A; Pavlevska E; Jovanoska B; Milenkovik T; Bitoska I; Jovanovska S
    Georgian Med News; 2023 May; (338):104-107. PubMed ID: 37419481
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changes in diagnosis and operative treatment of insulinoma over two decades.
    Wiese D; Humburg FG; Kann PH; Rinke A; Luster M; Mahnken A; Bartsch DK
    Langenbecks Arch Surg; 2023 Jun; 408(1):255. PubMed ID: 37386194
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
    Werle SD; Ikonomi N; Lausser L; Kestler AMTU; Weidner FM; Schwab JD; Maier J; Buchholz M; Gress TM; Kestler AMR; Kestler HA
    NPJ Syst Biol Appl; 2023 Jun; 9(1):22. PubMed ID: 37270586
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
    Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
    Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
    Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
    Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. pancreatic imaging in men1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
    Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. men1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes pancreatic Neuroendocrine Tumor Progression.
    Xu J; Ye Z; Zhuo Q; Gao H; Qin Y; Lou X; Zhang W; Wang F; Wang Y; Jing D; Fan G; Zhang Y; Chen X; Chen J; Xu X; Yu X; Ji S
    Cancer Res; 2023 Jul; 83(13):2226-2247. PubMed ID: 36939378
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiple Endocrine Neoplasia Type 1 Syndrome pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
    Ramamoorthy B; Nilubol N
    Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
    Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
    Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Aggressive versus indolent insulinomas: new clinicopathological insights.
    Hackeng WM; Brosens LAA; Dreijerink KMA
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.